Thomas M Atkinson

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi request reprint Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    J Cancer Res Clin Oncol . 2017
  2. pmc Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    J Cancer Res Clin Oncol . 2016
  3. pmc The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    Support Care Cancer 24:3669-76. 2016
  4. pmc The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    Support Care Cancer 23:3645-52. 2015
  5. pmc Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    J Behav Med 38:837-50. 2015
  6. pmc Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY 10022, USA
    Pain Med 13:1417-24. 2012
  7. pmc Development and preliminary evaluation of a training workshop for the collection of patient-reported outcome (PRO) interview data by research support staff
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Cancer Educ 28:33-7. 2013
  8. pmc Illness-related distress in women with clinically localized cutaneous melanoma
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:675-9. 2013
  9. pmc Reliability of adverse symptom event reporting by clinicians
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY 10022, USA
    Qual Life Res 21:1159-64. 2012
  10. doi request reprint Patterns of memory: a normative taxonomy of the Wide Range Assessment of Memory and Learning-Second Edition (WRAML-2)
    Thomas M Atkinson
    Department of Leadership, Foundations, and Policy, University of Virginia Curry School of Education, Charlottesville, Virginia, USA
    J Int Neuropsychol Soc 14:869-77. 2008

Detail Information

Publications20

  1. doi request reprint Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    J Cancer Res Clin Oncol . 2017
    ....
  2. pmc Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    J Cancer Res Clin Oncol . 2016
    ..Patient-reported health-related quality of life (HRQoL) data are becoming more frequent in oncology; however, the relationship between physician-adjudicated AE assessment and HRQoL is understudied...
  3. pmc The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    Support Care Cancer 24:3669-76. 2016
    ..The aim of this review was to summarize the empirically reported association between analogous CTCAE and PRO ratings...
  4. pmc The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    Support Care Cancer 23:3645-52. 2015
    ..Thus, the purpose of this study was to conduct a systematic review of the level of association between PRO and FPS measures to determine their differential or combined utility...
  5. pmc Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    J Behav Med 38:837-50. 2015
    ..02 vs. 0.16). We found a small, positive relationship between CRC risk perception and reported screening behavior, with important identified heterogeneity across moderators. Future studies should focus on high quality study design...
  6. pmc Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY 10022, USA
    Pain Med 13:1417-24. 2012
    ..g., mood) and activity (e.g., work) interference. The purpose of this analysis was to confirm this affective/activity interference dichotomy...
  7. pmc Development and preliminary evaluation of a training workshop for the collection of patient-reported outcome (PRO) interview data by research support staff
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Cancer Educ 28:33-7. 2013
    ..Training research support staff in the effective collection of PROs via patient interviews can improve the confidence of these individuals in interacting with patients, which can ultimately lead to increased accuracy of data collection...
  8. pmc Illness-related distress in women with clinically localized cutaneous melanoma
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:675-9. 2013
    ..In order to plan future interventions and identify areas of primary concern, we conducted a cross-sectional survey to describe the experiences of women treated for clinically localized melanoma...
  9. pmc Reliability of adverse symptom event reporting by clinicians
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY 10022, USA
    Qual Life Res 21:1159-64. 2012
    ..The purpose of this study was to assess the reliability of adverse event reporting of different clinicians for the same patient for the same visit...
  10. doi request reprint Patterns of memory: a normative taxonomy of the Wide Range Assessment of Memory and Learning-Second Edition (WRAML-2)
    Thomas M Atkinson
    Department of Leadership, Foundations, and Policy, University of Virginia Curry School of Education, Charlottesville, Virginia, USA
    J Int Neuropsychol Soc 14:869-77. 2008
    ..A summary of the defining characteristics for each profile is provided...
  11. doi request reprint Three trail making tests for use in neuropsychological assessments with brief intertest intervals
    Thomas M Atkinson
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    J Clin Exp Neuropsychol 32:151-8. 2010
    ..The study provides evidence that the three tests can be offered as potential alternative instruments in serial assessment...
  12. pmc The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Pain Med 11:337-46. 2010
    ..When finalized, it may provide a blueprint for evaluations of PRO measures that can be considered by sponsors and investigators involved in PRO research and drug registration trials...
  13. pmc Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI)
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Pain Symptom Manage 41:558-65. 2011
    ....
  14. doi request reprint Using versions of the trail making test as alternate forms
    Thomas M Atkinson
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
    Clin Neuropsychol 25:1193-206. 2011
    ..These findings support the notion that three different trail-making tests can be administered without discernable practice effects, increasing the flexibility of a serial neuropsychological assessment battery...
  15. pmc Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Ethan Basch
    Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC EB, BBR, AVB Department of Health Policy and Management, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC EB, BBR, AVB Department of Epidemiology and Biostatistics, Health Outcomes Research Group EB, LS, LR and Department of Psychiatry and Behavioral Sciences JH, TMA, Memorial Sloan Kettering Cancer Center, New York, NY Outcomes Research Branch, Applied Research Program, Division of Cancer Control and Population Sciences SAM, SBC, Division of Cancer Prevention LMM, NCTN Clinical Trials Operations, Cancer Therapy Evaluation Program AD, Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention AMO, DSG, JK, and Investigational Drug Branch, Cancer Therapy Evaluation Program AC, National Cancer Institute, Bethesda, MD Division of Health Sciences Research, College of Medicine, Mayo Clinic Arizona, Scottsdale, Unidad de Salud Respiratoria
    J Natl Cancer Inst 106:. 2014
    ..It is envisioned that the PRO-CTCAE will enhance the precision and patient-centeredness of adverse event reporting in cancer clinical research. ..
  16. pmc Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
    Ethan Basch
    Ethan Basch, Mark G Kris, Howard I Scher, Clifford A Hudis, Paul Sabbatini, Lauren Rogak, Thomas M Atkinson, Joanne F Chou, Dorothy Dulko, Laura Sit, Michael Fruscione, and Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, NY Ethan Basch, Allison M Deal, and Antonia V Bennett, University of North Carolina, Chapel Hill, NC Amylou C Dueck, Mayo Clinic, Scottsdale, AZ Allison Barz, Children s Hospital of Philadelphia, Philadelphia, PA Paul Novotny and Jeff A Sloan, Mayo Clinic, Rochester, MN and Deborah Schrag, Dana Farber Harvard Cancer Center, Boston, MA
    J Clin Oncol 34:557-65. 2016
    ..There is growing interest to enhance symptom monitoring during routine cancer care using patient-reported outcomes, but evidence of impact on clinical outcomes is limited...
  17. pmc Examining the Association between Patient-Reported Symptoms of Attention and Memory Dysfunction with Objective Cognitive Performance: A Latent Regression Rasch Model Approach
    Yuelin Li
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Arch Clin Neuropsychol 31:365-77. 2016
    ..An example analysis using these methods is also included...
  18. pmc Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Jennifer L Hay
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, 641 Lexington Ave, 7th Floor, New York, NY, 10022, USA
    Qual Life Res 23:257-69. 2014
    ..This study contributes content validity evidence of the PRO-CTCAE by incorporating cancer patient input of the relevance and comprehensiveness of the item library...
  19. pmc Reliable change in neuropsychological assessment of breast cancer survivors
    Charissa Andreotti
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Psychooncology 25:43-50. 2016
    ..Scores on standard neuropsychological instruments may be impacted by practice effects and other random forms of error...
  20. ncbi request reprint Executive functioning as a potential mediator of age-related cognitive decline in normal adults
    Timothy A Salthouse
    Dept of Psychology, University of Virginia, Charlottesville, VA 22904 4400, USA
    J Exp Psychol Gen 132:566-94. 2003
    ....